Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
SELECTA BIOSCIENCES INC (SELB)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2023 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 705 shares
@ $1.06, valued at
$747.3 |
|
06/01/2023 |
4
| Kishimoto Takashi Kei (Chief Scientific Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Gifted 43,000 shares
@ $0 Gifted 26,500 shares
@ $0 |
|
01/06/2023 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 27,549 shares
@ $1.1337, valued at
$31.2k
Sold 48 shares
@ $1.145, valued at
$55 Sold 13,396 shares
@ $1.1293, valued at
$15.1k
Sold 77 shares
@ $1.115, valued at
$85.9 |
|
01/06/2023 |
4
| Johnston Lloyd P. (Chief Operations Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 6,381 shares
@ $1.1337, valued at
$7.2k
Sold 11 shares
@ $1.1401, valued at
$12.5 Sold 3,372 shares
@ $1.1293, valued at
$3.8k
Sold 20 shares
@ $1.1104, valued at
$22.2 |
|
01/06/2023 |
4
| Kishimoto Takashi Kei (Chief Scientific Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 6,381 shares
@ $1.1337, valued at
$7.2k
Sold 11 shares
@ $1.145, valued at
$12.6 Sold 3,372 shares
@ $1.1293, valued at
$3.8k
Sold 20 shares
@ $1.1114, valued at
$22.2 |
|
01/06/2023 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 8,164 shares
@ $1.1337, valued at
$9.3k
Sold 15 shares
@ $1.142, valued at
$17.1 Sold 3,445 shares
@ $1.1293, valued at
$3.9k
Sold 20 shares
@ $1.1114, valued at
$22.2 |
|
01/04/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 87,500 options to buy
@ $1.13, valued at
$98.9k
|
|
01/04/2023 |
4
| ANDO GORAN (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
01/04/2023 |
4
| BARABE TIMOTHY C (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 87,500 options to buy
@ $1.13, valued at
$98.9k
|
|
01/04/2023 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 282,800 shares
@ $0 Granted 1,275,000 options to buy
@ $1.13, valued at
$1.4M
|
|
01/04/2023 |
4
| COX CARRIE SMITH (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 107,500 options to buy
@ $1.13, valued at
$121.5k
|
|
01/04/2023 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
01/04/2023 |
4
| Johnston Lloyd P. (Chief Operations Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 100,000 shares
@ $0 Granted 475,000 options to buy
@ $1.13, valued at
$536.8k
|
|
01/04/2023 |
4
| Kishimoto Takashi Kei (Chief Scientific Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 100,000 shares
@ $0 Granted 475,000 options to buy
@ $1.13, valued at
$536.8k
|
|
01/04/2023 |
4
| Sallin Aymeric (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
01/04/2023 |
4
| SPRINGER TIMOTHY A (10% Owner) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
01/04/2023 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 200,000 shares
@ $0 Granted 900,000 options to buy
@ $1.13, valued at
$1M
|
|
01/04/2023 |
4
| ZENNER PATRICK J (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/06/2022 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 4,768 shares
@ $1.8478, valued at
$8.8k
Exercised 10,937 restricted stock units
@ $0 |
|
06/15/2022 |
4
| COX CARRIE SMITH (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Bought 130,000 shares
@ $1.1523, valued at
$149.8k
|
|
06/03/2022 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Exercised 10,938 restricted stock units
@ $0 |
|
05/11/2022 |
4
| BARABE TIMOTHY C (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Bought 50,000 shares
@ $0.7744, valued at
$38.7k
|
|
04/13/2022 |
4
| SPRINGER TIMOTHY A (10% Owner) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Bought 6,681,600 shares
@ $0 Granted 5,011,200 warrants
@ $1.55, valued at
$7.8M
|
|
03/03/2022 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 5,443 shares
@ $1.8121, valued at
$9.9k
Exercised 10,937 restricted stock units
@ $0 |
|
01/18/2022 |
4
| BARABE TIMOTHY C (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Exercised 10,000 options to buy
@ $2.1, valued at
$21k
|
|
01/07/2022 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 3,226 shares
@ $3.0859, valued at
$10k
|
|
01/07/2022 |
4
| Kishimoto Takashi Kei (Chief Scientific Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 3,416 shares
@ $3.0859, valued at
$10.5k
|
|
01/07/2022 |
4
| Johnston Lloyd P. (Chief Operations Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 3,416 shares
@ $3.0859, valued at
$10.5k
|
|
01/07/2022 |
4
| Brunn Carsten (President and CEO) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Sold 13,597 shares
@ $3.0859, valued at
$42k
|
|
|
|
|